Impaired glucose tolerance as a disease

American Journal of Cardiology

Volumn 88, Issue 2 SUPPL. 2, 2001, Pages

  Baron, Alain D ^a  

^a AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; ALPHA GLUCOSIDASE INHIBITOR; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; SIMVASTATIN;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETIC OBESITY; DIAGNOSTIC ACCURACY; DIET RESTRICTION; DISEASE COURSE; DISEASE MARKER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; SYNDROME X; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC DIET; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; MICROANGIOPATHY; OBESITY; PREDICTION; RISK ASSESSMENT; SENSITIZATION; SYMPTOM;

CORONARY DISEASE; DIET; EXERCISE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION; OBESITY;

EID: 0035954510     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9149(01)01832-x     Document Type: Review

References (24)

1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
2. Diabetes mellitus
3. Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance
4. Comparison of diabetes diagnostic categories in the US population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria
5. Heart disease and diabetes
6. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study
7. Diabetes, other risk factors, and 12-year mortality for men screened in the Multiple Risk Factor Intervention Trial
8. The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease
9. The relationship between glucose and incident cardiovascular events: A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years
10. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance
11. Glucose intolerance, physical signs of peripheral artery disease, and risk of cardiovascular events: The Framingham Heart Study
12. Is there a glycemic threshold for mortality risk?
13. Impaired glucose tolerance: A risk factor for type 2 diabetes and cardiovascular disease
14. Glucose intolerance and 23-year risk of coronary heart disease and total mortality: The Honolulu Heart Program
15. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men: The Chicago Heart Association Detection Project in Industry Study
16. A comparison of the relationships of the glucose tolerance test and the glycated hemoglobin assay with diabetic vascular disease in the community: The Islington Diabetes Survey
17. The Diabetes Prevention Program: Design and methods for a clinical trial in the prevention of type 2 diabetes
18. The STOP-NIDDM Trial: An international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: Rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus
19. Role of insulin resistance in human disease
20. Insulin resistance implications for type II diabetes mellitus and coronary heart disease
21. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: Implications for preventing coronary disease during the prediabetic state
22. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: The Funagata Diabetes Study
23. The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease
24. The benefits of lowering cholesterol in subjects with mild hyperglycemia